3 ASX Growth Stocks With Up To 12% Insider Ownership
In This Article:
As the ASX200 shows a modest increase of 0.45% amidst steady unemployment rates and sector-specific fluctuations, investors are keenly observing growth opportunities within the Australian market. In this environment, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best, aligning well with current trends in IT and Financials sectors which have shown resilience.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Medallion Metals (ASX:MM8) | 12.9% | 72.7% |
| Catalyst Metals (ASX:CYL) | 14.8% | 33.1% |
| Genmin (ASX:GEN) | 12.3% | 117.7% |
| Acrux (ASX:ACR) | 18.4% | 91.6% |
| AVA Risk Group (ASX:AVA) | 15.7% | 77.3% |
| Pointerra (ASX:3DP) | 20.8% | 126.4% |
| Hillgrove Resources (ASX:HGO) | 10.4% | 67.1% |
| Findi (ASX:FND) | 34.8% | 64.8% |
| Plenti Group (ASX:PLT) | 12.8% | 107.6% |
| Brightstar Resources (ASX:BTR) | 16.2% | 84.6% |
Here's a peek at a few of the choices from the screener.
Alpha HPA
Simply Wall St Growth Rating: ★★★★★☆
Overview: Alpha HPA Limited is a specialty metals and technology company with a market capitalization of A$1.11 billion.
Operations: The company's revenue is primarily derived from its HPA First Project, contributing A$0.04 million.
Insider Ownership: 12.6%
Alpha HPA is experiencing significant revenue growth, forecasted at 103% per year, outpacing the Australian market's average of 5.7%. Despite its low current revenue (A$44K) and a net loss of A$24.98 million for the last fiscal year, it is expected to become profitable within three years. However, shareholders faced dilution over the past year, and its return on equity is projected to remain low at 3.8%.
PolyNovo
Simply Wall St Growth Rating: ★★★★★☆
Overview: PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally with a market cap of A$1.42 billion.
Operations: The company's revenue primarily stems from the development, manufacturing, and commercialization of the NovoSorb Technology, amounting to A$103.23 million.
Insider Ownership: 10.2%
PolyNovo's earnings are forecast to grow significantly at 38.4% annually, outpacing the Australian market. Despite recent changes in executive leadership with the retirement of a long-standing director, insider activity shows more shares bought than sold recently, indicating confidence in its growth trajectory. The company reported A$104.76 million in revenue for the fiscal year ending June 2024, marking substantial improvement from the previous year's results and achieving profitability with net income of A$5.26 million.